Va Endo & Osteo Center Midlothian, VA - 23114

Va Endo & Osteo Center is categorized under Endocrinologists in Midlothian, VA and active since 2005.

Va Endo & Osteo Center was established in 2005, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Endocrinologists business, which does work in the B2C market, and is classified as a Endocrinologists, under code number 621111 by the NAICS.

If you are seeking more information, feel free to contact Shari Lynn Moyers at the company’s single location by writing to 13700 St Francis Boulevard # 505, Midlothian, Virginia VA 23114 or by phoning (804) 423-3636. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Va Endo & Osteo Center
Contact Person: Shari Lynn Moyers
Address: 13700 St Francis Boulevard # 505, Midlothian, Virginia 23114
Phone Number: (804) 423-3636
Website Address: virginiaendo.com
Annual Revenue (USD): $100.000 to $499.999
Founded: 2005
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Endocrinologists
SIC Code: 8011
NAICS Code: 621111
Share This Business:

Va Endo & Osteo Center was started in 2005 to provide professional Endocrinologists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Shari Lynn Moyers for inquiries that concern Va Endo & Osteo Center by calling the company number (804) 423-3636, as your correspondence is most welcome. Additionally, the physical location of the single location of Va Endo & Osteo Center can be found at the coordinates 37.465837,-77.658888 as well as the street address 13700 St Francis Boulevard # 505 in Midlothian, Virginia 23114.

For its online presence, you may visit Va Endo & Osteo Center’s website at virginiaendo.com and engage with its social media outlets through on Twitter and on Facebook.